The future belongs to nano-diagnostics

Diagnostics is the future of biotech, now that diagnostics and therapy are linked more than ever. Consider breast cancer, gene signatures like HER2, serve two purposes- diagnosing the disease and dictating the treatment. To me, tomorrow diagnostics do not merely dictate therapy, but incorporate preventative care by monitoring. This means, we need new devices for… Continue reading The future belongs to nano-diagnostics